University of Utah
Salt Lake City, Utah, 84132, United States
NCT Number: NCT02218866
The goal of this research is understand if obesity is a major factor for neuropathy development in patients with and without Type 2 diabetes. This study will examine the relationship between weight, metabolism, and nerve function and regeneration.
Looking for future studies?
Notify Me18 year–80 year
All sexes
Observational
Salt Lake City, Utah, 84132, United States
Peripheral neuropathy causes progressive injury to the longest nerves of the body, starting in the toes, then progressing slowly up the leg. Neuropathy often causes pain, numbness, and weakness if the feet and can lead to reduced mobility, foot ulcers, and even amputation. The most common cause is diabetes, but work at the University of Utah finds that prediabetes and other consequences of obesity, including abnormal cholesterol levels, may be associated with neuropathy. Research has shown that these risk factors may damage nerves and interfere with the ability of nerves to grow back after an injury.
This study aims to
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 4 - 1 months prior to bariatric surgery, compared to 9 - 12 months after surgery
Time frame: Baseline to 12 months after bariatric surgery
Time frame: Baseline to 12 months after bariatric surgery
Nerve Conduction Study is a procedure routinely used in the diagnosis of neuropathy. Measures will include Sural sensory and Peroneal motor amplitudes and conduction velocities.
Time frame: Baseline to 12 months after bariatric surgery
University of Utah
Other
Acronym: BAR
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05623449
Nervous System Diseases, Neurologic Manifestations
Pessac, France
View Trial DetailsNCT06030297
Nervous System Diseases, Neuralgia
Palo Alto, California, United States
View Trial DetailsNCT06499129
Anxiety, Anxiety Disorders
Konya, Meram, Turkey (Türkiye)
View Trial DetailsNCT05821127
Behavior, Carpal Tunnel Syndrome
Istanbul, Turkey (Türkiye)
View Trial Details